Summary

The Global Smoking Cessation and Nicotine De-Addiction Products Market is valued at approximately USD 24.54 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 10.77% over the forecast period 2024-2032. Smoking cessation refers to the act of quitting smoking, and nicotine, an alkaloid, creates dependency on cigarettes and other smoking products. According to the Center for Disease Control and Prevention (CDC), smoking is linked to numerous chronic diseases, including lung cancer, COPD, and asthma. With approximately 30.8 million adults in the U.S. currently smoking and more than 16 million Americans suffering from smoking-related diseases, there has been a notable shift towards e-cigarettes, which are battery-powered devices generating an inhaled aerosol and perceived as less harmful.
Various government initiatives, such as increased awareness of smoking-related diseases, and anti-smoking campaigns by leading organizations have driven the demand for smoking cessation products, leading to significant market growth. Additionally, major market players are heavily investing in the development of advanced smoking cessation products, attracting younger smokers and further propelling market growth. Furthermore, in the UK, the license for some nicotine replacement therapies has been extended to allow longer-term use for those not willing or able to quit immediately, thereby facilitating an increase in sales of cessation products globally. However, the high cost of these therapies and limited compatibility with existing systems may hinder market growth during the forecast period.
The key regions considered for the Global Smoking Cessation and Nicotine De-Addiction Products Market study include Asia Pacific, North America, Europe, Latin America, and the Middle East & Africa. In 2023, North America holds largest market share due to the presence of key players, rising government initiatives, well-developed healthcare infrastructure, and the high prevalence of smoking-related diseases. The market is also influenced due to the due to high awareness of the health risks associated with smoking and substantial healthcare resources dedicated to combating nicotine addiction. The region benefits from a well-established healthcare infrastructure, extensive public health campaigns, and a range of available cessation aids, including prescription medications, nicotine replacement therapies, and digital support tools. Additionally, regulatory support and insurance coverage for smoking cessation treatments further bolster market growth. As the demand for effective smoking cessation solutions continues to rise, North America's market remains the largest and most advanced globally. Asia-Pacific is expected to witness the highest growth rate throughout the forecast period, driven by increasing numbers of smokers quitting, government and organizational anti-smoking initiatives, and approved smoking cessation drugs.

Major market players included in this report are:
British American Tobacco Inc.
22nd Century Group Inc.
Cipla Ltd.
Dr. Reddy’s Laboratories Ltd.
GlaxoSmithKline PLC (Haleon)
Imperial Brands Plc. (Fontem Ventures)
Johnson and Johnson (McNeil Consumer Health)
Njoy Company
Pfizer Inc.
Perrigo Company Plc.
Rusan Pharma
Zydus Cadila

The detailed segments and sub-segment of the market are explained below:
By Product:
Nicotine Replacement Therapy Products
Drug Therapy
E-cigarettes

By Form:
Gum
Inhaler
Tablet
Others

By Distribution Channel:
Hospital Pharmacies
Online Providers
Drug Stores and Retail Pharmacies

By Region:
North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
Rest of Europe

Asia Pacific
China
India
Japan
Australia
South Korea
Rest of Asia Pacific

Latin America
Brazil
Mexico
Rest of Latin America

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

By Region:
North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico
Rest of Latin America

Middle East & Africa
Saudi Arabia
South Africa
RoMEA

Years considered for the study are as follows:
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032

Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.

ページTOPに戻る

Table of Contents

Chapter 1. Global Smoking Cessation and Nicotine De-Addiction Products Market Executive Summary
1.1. Global Smoking Cessation and Nicotine De-Addiction Products Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Product
1.3.2. By Form
1.3.3. By Distribution Channel
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Smoking Cessation and Nicotine De-Addiction Products Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates

Chapter 3. Global Smoking Cessation and Nicotine De-Addiction Products Market Dynamics
3.1. Market Drivers
3.1.1. Increasing Awareness and Government Initiatives
3.1.2. Shift Towards E-cigarettes
3.1.3. Technological Advancements in Cessation Products
3.2. Market Challenges
3.2.1. High Cost of Therapies
3.2.2. Limited Compatibility with Existing Systems
3.3. Market Opportunities
3.3.1. Rise in Expenditure on Mobile Phone Accessories
3.3.2. Growth in Online Sales Channels
3.3.3. Increasing Investment in R&D by Market Players

Chapter 4. Global Smoking Cessation and Nicotine De-Addiction Products Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Smoking Cessation and Nicotine De-Addiction Products Market Size & Forecasts by Product 2022-2032
5.1. Segment Dashboard
5.2. Global Smoking Cessation and Nicotine De-Addiction Products Market: Product Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Nicotine Replacement Therapy Products
5.2.2. Drug Therapy
5.2.3. E-cigarettes

Chapter 6. Global Smoking Cessation and Nicotine De-Addiction Products Market Size & Forecasts by Form 2022-2032
6.1. Segment Dashboard
6.2. Global Smoking Cessation and Nicotine De-Addiction Products Market: Form Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Gum
6.2.2. Inhaler
6.2.3. Tablet
6.2.4. Others

Chapter 7. Global Smoking Cessation and Nicotine De-Addiction Products Market Size & Forecasts by Distribution Channel 2022-2032
7.1. Segment Dashboard
7.2. Global Smoking Cessation and Nicotine De-Addiction Products Market: Distribution Channel Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Hospital Pharmacies
7.2.2. Online Providers
7.2.3. Drug Stores and Retail Pharmacies

Chapter 8. Global Smoking Cessation and Nicotine De-Addiction Products Market Size & Forecasts by Region 2022-2032
8.1. North America Smoking Cessation and Nicotine De-Addiction Products Market
8.1.1. U.S. Smoking Cessation and Nicotine De-Addiction Products Market
8.1.1.1. Product breakdown size & forecasts, 2022-2032
8.1.1.2. Form breakdown size & forecasts, 2022-2032
8.1.1.3. Distribution Channel breakdown size & forecasts, 2022-2032
8.1.2. Canada Smoking Cessation and Nicotine De-Addiction Products Market
8.2. Europe Smoking Cessation and Nicotine De-Addiction Products Market
8.2.1. U.K. Smoking Cessation and Nicotine De-Addiction Products Market
8.2.2. Germany Smoking Cessation and Nicotine De-Addiction Products Market
8.2.3. France Smoking Cessation and Nicotine De-Addiction Products Market
8.2.4. Spain Smoking Cessation and Nicotine De-Addiction Products Market
8.2.5. Italy Smoking Cessation and Nicotine De-Addiction Products Market
8.2.6. Rest of Europe Smoking Cessation and Nicotine De-Addiction Products Market
8.3. Asia-Pacific Smoking Cessation and Nicotine De-Addiction Products Market
8.3.1. China Smoking Cessation and Nicotine De-Addiction Products Market
8.3.2. India Smoking Cessation and Nicotine De-Addiction Products Market
8.3.3. Japan Smoking Cessation and Nicotine De-Addiction Products Market
8.3.4. Australia Smoking Cessation and Nicotine De-Addiction Products Market
8.3.5. South Korea Smoking Cessation and Nicotine De-Addiction Products Market
8.3.6. Rest of Asia Pacific Smoking Cessation and Nicotine De-Addiction Products Market
8.4. Latin America Smoking Cessation and Nicotine De-Addiction Products Market
8.4.1. Brazil Smoking Cessation and Nicotine De-Addiction Products Market
8.4.2. Mexico Smoking Cessation and Nicotine De-Addiction Products Market
8.4.3. Rest of Latin America Smoking Cessation and Nicotine De-Addiction Products Market
8.5. Middle East & Africa Smoking Cessation and Nicotine De-Addiction Products Market
8.5.1. Saudi Arabia Smoking Cessation and Nicotine De-Addiction Products Market
8.5.2. South Africa Smoking Cessation and Nicotine De-Addiction Products Market
8.5.3. Rest of Middle East & Africa Smoking Cessation and Nicotine De-Addiction Products Market

Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Company 1
9.1.2. Company 2
9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. 22nd Century Group Inc.
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Market Strategies
9.3.2. Cipla Ltd.
9.3.3. Dr. Reddy’s Laboratories Ltd.
9.3.4. Imperial Brands Plc. (Fontem Ventures)
9.3.5. Johnson and Johnson (McNeil Consumer Health)
9.3.6. Njoy Company
9.3.7. Perrigo Company Plc.
9.3.8. Rusan Pharma
9.3.9. Zydus Cadila
9.3.10. British American Tobacco Inc.
9.3.11. GlaxoSmithKline PLC (Haleon)
9.3.12. Pfizer Inc.


Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes